In 17 healthy men, beta-adrenergic blockade reduced significantly the tachycardia and the elevation of cardiac output associated with inhalation of 7.5% oxygen for 7 to 10 minutes.
Introduction
Acutely induced hypoxia in man produces an increase in cardiac output, in heart rate, and in forearm blood flow (1) and a decrease in blood flow to the hand (2), but little change in arterial pressure. The mechanisms by which hypoxia produces these circulatory changes remain incompletely understood. A striking similarity exists between these circulatory responses and those produced by intravenous infusion of epinephrine (3, 4) . It has been suggested (1) that liberation of epinephrine contributes to the circulatory responses to hypoxia, although recent measurement of serum catecholamine concentration during hypoxia in the dog shows little change (5) . These considerations led us to study the influences of the sympathetic nervous system and of catecholamines as possible mediators of the circulatory responses to acute hypoxia.
Three approaches to evaluation of the contribution of circulating catecholamines and of sympathetic neural activity during hypoxia are used: 1) blockade of the positive chronotropic and inotropic cardiac effects of sympathetic nerve activity and of circulating catecholamines by use of betaadrenergic blocking agents, 2) measurement of the concentration of catecholamines in arterial blood during hypoxia, and 3) local blockade of alphaand beta-adrenergic receptors in forearm blood vessels. Methods Subjects were 30 healthy male volunteers, aged 19 to 39 years. All experiments were performed in an air-conditioned laboratory (room temperature, 23 to 240 C) with the subjects recumbent on a table.
Cardiac output was measured by an indicator-dilution method. Through a 3-inch polyethylene catheter, in-77 serted in an antecubital vein and advanced into the median basilic vein, a known amount of indocyanine green was injected rapidly, and immediately followed by 20 ml of isotonic saline injected into the vein in 2 or 3 seconds. Injection of dye into an antecubital vein has been shown by Bousvaros and others (6) (7) (8) to give values for cardiac output equal to those obtained by injection into the pulmonary artery or right atrium if the injection of dye is immediately followed by saline to propel the dye into the central circulation. Dye concentration in arterial blood was measured continuously with a Gilford densitometer.
Arterial blood pressure was recorded with a Statham P23D strain gauge connected to an 18-inch Cournand needle in a brachial artery. Mean pressure was obtained by electronic damping. Systemic vascular resistance was calculated as the ratio of mean arterial blood pressure to cardiac index. Arterial blood was collected in heparinized syringes anaerobically, and its oxygen and carbon dioxide tensions and pH were measured with oxygen and carbon dioxide electrodes (9) and a Metrohm pH meter at 37°C. Forearm blood flow was measured by venous occlusion plethysmography with either Whitney mercury-in-rubber strain gauges or water-filled plethysmographs in which the water temperature was maintained at 340 C. The mercury-in-rubber strain gauges were calibrated according to the method of Whitney (10) . During measurement of forearm blood flow, the circulation to the hand was excluded by inflating a wrist cuff to 250 mm Hg. Forearm vascular resistance was calculated as the ratio of mean arterial blood pressure to forearm blood flow. Measurements of forearm blood flow were not made on the same day as were those of cardiac output.
To induce hypoxia, the subjects breathed 7.5%o oxygen in nitrogen from a Douglas bag by means of a mouthpiece and low resistance valve system. Plasma concentrations of epinephrine and norepinephrine were measured by the trihydroxy indole method in six subjects during inhalation of room air and during the tenth minute of inhalation of 7.5% oxygen in nitrogen. The catecholamines were extracted from plasma with an alumina column as described by Crout (11) and differentially assayed by the procedure of Wiegand and Perry (12) .
Beta-adrenergic blockade was produced in ten subjects by intravenous administration of 0.8 to 1.5 mg per kg of pronethalol given over a period of 5 minutes. After its administration, intravenous infusion of 10 ug per minute of epinephrine produced hypertension and bradycardia in each subject. The subsequent availability of propranolol, a more potent beta-adrenergic blocking drug (13) , led us to study the effect of this agent on the changes in cardiac output, heart rate, and arterial blood pressure induced by hypoxia in seven additional subjects, using an experimental protocol identical to that for pronethalol, except that the subjects received 5 mg of propranolol intravenously. ' The effect of beta-adrenergic blockade on the general circulatory response to hypoxia was studied as follows:
Control measurements of cardiac output, blood pressure, arterial blood gas tensions, and pH were made while the subjects breathed room air and were repeated during the seventh and eighth minutes of breathing 7.5%o oxygen in nitrogen. After Beta-adrenergic blockade of the forearm only was produced by the injection of 15 mg of pronethalol into the brachial artery over a period of 5 minutes. After intraarterial administration of pronethalol, intravenous administration of 10 Ag per minute of epinephrine produced a slight decrease in forearm blood flow instead of the usual increase. Alpha-adrenergic blockade of the forearm was produced by the intra-arterial administration of 8 mg of phenoxybenzamine over a period of 5 minutes. The effectiveness of blockade was verified by showing abolition of the decrease in forearm blood flow that normally accompanies the post-Valsalva "overshoot" in blood pressure ( Figure 1 ). Roddie, Shepherd, and Whelan (14) have demonstrated that this decrease in forearm blood flow is mediated by increased activity of adrenergic sympathetic nerves. Figures 2 and 3 show the change in forearm blood flow induced by epinephrine, 10 /Ag per minute intravenously, and the modification of this effect by blockade of alpha-and of alpha-and betaadrenergic receptors, respectively.
The effect of beta-adrenergic or alpha-adrenergic blockade of the forearm on its circulatory response to hypoxia was studied as follows: Beta-adrenergic or alpha-adrenergic blockade of the forearm was produced in one forearm. Blood flow was measured simultaneously in both forearms as the subjects breathed room air and during the first 8 minutes of breathing 7.5% oxygen in nitrogen. In seven additional experiments, blood flow was measured in only one arm after the intra-arterial administration of phenoxybenzamine and the response to hypoxia determined as noted above. After a 15-minute rest period, pronethalol was given intra-arterially into the brachial artery of the same arm and the response to hypoxia recorded again.
The results were analyzed statistically by comparing the mean difference between control and hypoxic measurements to zero by the t test (15) . In comparing the effects of hypoxia on intact forearm vessels with its effects after phenoxybenzamine, we used per cent change in blood flow and vascular resistance in statistical analysis because of the marked difference in blood flow through the intact and the phenoxybenzamine-treated extremity before hypoxia. heart rate increased 41 %, from 72 to 101 beats increase in heart rate, from 70 to 100 beats per per minute, during hypoxia before beta-adrenergic minute (Table II) . After administration of problockade, but only 30%o, from 70 to 91 beats per pranolol, inhalation of 7.5%o oxygen produced only minute, after pronethalol. The increases in both a 28%o increase in cardiac index, from 2.5 to 3.1 cardiac output and heart rate induced by hypoxia L per minute per M2, and a 38%o increase in were significantly (p < 0.01) less pronounced heart rate, from 61 to 84 beats per minute, despite after pronethalol. Arterial pressure did not change reduction in arterial oxygen tension below that significantly during hypoxia before or after pro-in the control experiments. nethalol. Systemic vascular resistance fell from Five additional subjects breathed 7.5% oxygen 34 to 26 mm Hg per L per minute per m2 during twice, without any blocking agent, to evaluate the hypoxia after pronethalol, the decrease occurring possibility that the second exposure to hypoxia with pronethalol being significantly (p < 0.01) might produce less rise in cardiac output and less than the decrease from 33 to 21 mm Hg per heart rate than did the first, even though no block-L per minute per M2, which occurred during ing drug had been given. Cardiac index increased hypoxia before pronethalol. Changes in arterial an average of 1.4 + 0.6 (SEM) L per minute per CO2 tension and pH induced by hypoxia were m2 during the first exposure to 7.5%o oxygen, similar before and after pronethalol. and 1.5 + 0.4 L per minute per m2 during the In the seven subjects who received propranolol, second. Heart rate increased 30 ± 5 and 28 ± 4 t Blood flow was measured simultaneously in both arms, into one of which pronethalol had been injected intraarterially. tered epinephrine, 10 ug per minute. Vascular resistance in the intact forearm decreased by 25%o, from 42 to 32 mm Hg per ml per 100 ml per minute. In the pronethalol-treated forearm, hypoxia reduced vascular resistance from 28 to 23 mm Hg per ml per 100 ml per minute, a change not significantly different from that in the intact arm. B) Blockade of alpha-adrenergic receptors. Table V compares the effects of hypoxia on blood flow in the intact and phenoxybenzamine-treated forearms of six subjects. Forearm blood flow increased 27 and 28%o in the forearms during exposure to 7.5%o 02 Forearm vascular resistance decreased 29%o in the forearm that had received phenoxybenzamine and 217o in the intact forearm, but the difference was not statistically significant. C) Blockade of both alpha-and beta-adrenergic receptors. Administration of phenoxybenzamine in the above experiments produced a large increase in forearm blood flow and decrease in forearm vascular resistance, so that the state of the blood vessels, in particular their caliber, in the intact and phenoxybenzamine-treated forearm was substantially different. To exclude the possibility that this factor influenced the results, we observed the forearm vascular response to hypoxia in seven additional experiments in the same forearm, first after alpha-adrenergic blockade and then after blockade of both alpha-and beta-adrenergic receptors. The increase in forearm blood flow and decrease in forearm vascular resistance during hypoxia were not significantly different with phenoxybenzamine plus pronethalol from the corresponding changes seen with phenoxybenzamine alone, although the decrease in arterial oxygen tension was slightly greater with phenoxybenzamine plus pronethalol (Table VI) . (17) suggested that vasodilation in the forearm during hypoxia is due to the accom-panying hypocapnia, because the vasodilation was reduced when carbon dioxide was added to the inspired low-oxygen gas mixture. As reported elsewhere (18), this conclusion was not justified, because when carbon dioxide was added to the inspired hypoxia gas mixture, alveolar ventilation increased with consequent substantial increase in the mean arterial blood oxygen tension (from 37 to 52 mm Hg). When arterial blood CO2 tension was maintained at the control level, and at the same time the concentration of inspired oxygen reduced to bring the arterial blood oxygen tension to the same level as during hypocapnic hypoxia, the vasodilator response to hypoxia without hypocapnia was equal to that during hypocapnic hypoxia (18) . Thus, hypocapnia cannot account for the forearm vasodilation induced by hypoxia.
Animal experiments suggest that hypoxic vasodilation in skeletal muscle results from a direct effect of hypoxia on the smooth muscle of the high resistance blood vessels (19) or from release of vasodilator metabolites from the hypoxic tissues, which in turn dilate the high resistance blood vessels. In this respect, Imai, Riley, and Berne (20) showed that adenosine appears in hypoxic cardiac muscle but not in hypoxic skeletal muscle. Hence adenosine cannot be the cause of hypoxic vasodilation in skeletal muscle.
Cardiac output. Blockade of beta-adrenergic receptors reduced by about half the elevation in cardiac output and heart rate produced by hypoxia. Since the plasma concentration of catecholamines did not increase measurably in our experiments, and since the responses of the forearm vascular bed to hypoxia are not consistent with an increased blood concentration of catecholamines, the modification by beta-adrenergic blocking agents of the circulatory effects of hypoxia can be reasonably attributed to blockade of the effect of cardiac sympathetic nerves. This conclusion is consistent with the findings of Downing and Siegel (21) that systemic hypoxia in the cat results in marked increase in cardiac sympathetic discharge via the inferior cardiac nerve.
Beta-adrenergic blockade reduced but did not abolish completely the increase in cardiac output and heart rate induced by hypoxia. This may be the result of incomplete blockade of the effects of cardiac sympathetic nerves or of the operation of additional mechanisms leading to elevation of cardiac output during hypoxia. Increased venous return due to venoconstrictlon (22) and the resulting operation of the Frank-Starling mechanism, release of vagal inhibition, and a response by the heart to the peripheral vasodilation and lowered systemic vascular resistance induced by hypoxia are obvious possibilities.
The conclusion that blockade of the effects of increased stimulation of cardiac sympathetic nerves modifies the circulatory effects of hypoxia differs from that of previous workers. Harris, Bishop, and Segel (23) found that guanethidine, in a dose sufficient to abolish the post-Valsalva "overshoot" in arterial blood pressure, did not modify the cardiovascular responses to the hypoxia induced by breathing 13% oxygen. The increases in cardiac output and heart rate observed by these authors during hypoxia were small before administration of guanethidine and insignificant during the effect of guanethidine. It is possible, therefore, that the lack of significant effect of guanethidine may have been related to the mildness of the hypoxia, which resulted in circulatory changes of insufficient magnitude. Chidsey, Frye, Kahler, and Braunwald (24) found no significant difference in the changes in cardiac output and heart rate induced by inhalation of 12% oxygen before and after syrosingopine. Inability to evaluate the efficacy of sympathetic blockade with syrosingopine and incomplete understanding of the mechanisms of action of reserpine analogs complicate interpretation of their results.
Afferent and central nervous pathways by which hypoxia could stimulate cardiac sympathetic nerves in man are uncertain. In the dog the primary effects of perfusion of the carotid chemoreceptors with hypoxic blood are bradycardia, decrease in cardiac output, and peripheral vasoconstriction (25, 26) . Thus, in the dog the carotid chemoreceptors do not form the afferent limb responsible for stimulation of cardiac sympathetic nerves during systemic hypoxia, which is accompanied by tachycardia and increased cardiac output; Downing, Mitchell, and Wallace (27) have suggested that the central nervous system itself is the receptor area responsible for cardiac sympathetic nerve discharge during hypoxia. The elevation in cardiac output and heart rate during systemic hypoxia in the dog is, to a large extent, secondary to increase in ventilation, acting by reflex mecha-nisms related to inflation of the lung (28) . Increased ventilation is not a likely cause of the circulatory changes during hypoxia in man, since vigorous voluntary hyperventilation during which hypocapnia is prevented does not altar cardiac output or heart rate (29) .
